Why we don’t actively participate in patient advocacy, political campaigning and lobbyingWe believe we can provide the greatest value to our supporters and maximise our impact against cancer by focusing on funding the most innovative and high-quality cancer research we can, worldwide. This is what we do, and we do it very well.
The type of early-stage research we fund provides that vital seed of discovery needed to drive forward new and better ways of preventing, diagnosing, and treating cancer. Because we are not involved in clinical trials and do not directly work with patient groups or industry, we are not in a position to take part in patient advocacy, or comment on political and lobbying issues.
However we believe the patient voice is integral to the fight against cancer, and there are many UK-based and international patient advocacy and support groups who are here to help. If you are in the UK and you feel you have something which needs to be heard we would also urge you to contact your local MP.
In the case of science and research policy matters which directly impact us, we will usually support the position taken by the Association of Medical Research Charities (AMRC), an umbrella membership body representing UK-based medical research charities.